Volume 199, Issue 6, Supplement B , Pages S328-S332, December 2008
The clinical content of preconception care: women with psychiatric conditions
For a substantial proportion of women, pregnancy can be complicated by the occurrence or reoccurrence of a psychiatric condition. Psychiatric disorders during pregnancy are associated with poor obstetric outcomes, higher risk of postpartum psychiatric illness, increased rates of substance abuse, lower participation in prenatal care, and adverse infant and family outcomes. As part of preconception care, providers should be vigilant and screen for psychiatric disorders among women of reproductive age, as the detection and appropriate management of these conditions can reduce the occurrence of adverse pregnancy and family outcomes. This manuscript reviews the treatment options and the risks and benefits of discontinuing, changing, or continuing psychotropic medications for women of reproductive age with common psychiatric disorders (depression and anxiety disorders, bipolar disorder, and schizophrenia) and offers recommendations for preconception care.
Key words: anxiety, bipolar, depression, preconception, schizophrenia
Conflict of Interest: Ariela Frieder, MD; Anne L. Dunlop, MD, MPH; and Peter S. Bernstein, MD, MPH have no conflict of interest including grants, honoraria, advisory board membership, or share holdings. Larry Culpepper, MD, MPH is a consultant or is on the advisory board of Forest Labs, New York, NY; Pfizer, New York, NY; Wyeth, Madison, NJ; AstraZeneca, Wilmington, DE; Lilly, Indianapolis, IN; and Cephalon, Frazer, PA. He is on a Speakers Bureau for Forest Labs, Pfizer, and Wyeth.
PII: S0002-9378(08)01039-9
doi:10.1016/j.ajog.2008.09.001
© 2008 Mosby, Inc. All rights reserved.
Volume 199, Issue 6, Supplement B , Pages S328-S332, December 2008

